These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7036988)
41. Applications of monoclonal antibodies to neuroscience research. Valentino KL; Winter J; Reichardt LF Annu Rev Neurosci; 1985; 8():199-232. PubMed ID: 2580471 [TBL] [Abstract][Full Text] [Related]
42. A novel approach for obtaining and identifying monoclonal antibodies that react with differentiation-specific antigens using human hybrid cells. Stanbridge EJ; Araujo D; Ross P; Butler G; McCullough J; Wilkinson J Cancer Res; 1986 Sep; 46(9):4759-64. PubMed ID: 3731123 [TBL] [Abstract][Full Text] [Related]
43. Regulation of myeloma growth in mice by antigen and regulatory idiotopes. Rubinstein LJ; Bona CA Cancer Res; 1986 Apr; 46(4 Pt 1):1603-7. PubMed ID: 3948149 [TBL] [Abstract][Full Text] [Related]
44. Tumor hybrid cells: an immunotherapeutic agent. Parkman R J Natl Cancer Inst; 1974 May; 52(5):1541-5. PubMed ID: 4831439 [No Abstract] [Full Text] [Related]
45. Generation of monoclonal antibodies to surface proteins of human multiple myeloma employing membrane extracts for murine in vivo immunizations. Ravi M; Balaji S; Srinivasan L; Paul SF Hybridoma (Larchmt); 2009 Oct; 28(5):369-71. PubMed ID: 19857119 [TBL] [Abstract][Full Text] [Related]
46. Cell surface antigens of human melanoma identified by monoclonal antibody. Yeh MY; Hellström I; Brown JP; Warner GA; Hansen JA; Hellström KE Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2927-31. PubMed ID: 288077 [TBL] [Abstract][Full Text] [Related]
47. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer. Cote RJ; Morrissey DM; Oettgen HF; Old LJ Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400 [TBL] [Abstract][Full Text] [Related]
48. Antibody effects on membrane antigen expression. Cohen EP; Liang W Curr Top Dev Biol; 1979; 13 Pt 1():281-304. PubMed ID: 396119 [No Abstract] [Full Text] [Related]
49. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies. Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S Year Immunol; 1993; 7():213-9. PubMed ID: 8396821 [No Abstract] [Full Text] [Related]
50. A hybrid cell line producing anti-PreS2 monoclonal antibody for detection of PreS2 antigen. Xia MQ; Ji HP; Meng Q; Li XF; Tao QM Chin Med J (Engl); 1988 Jun; 101(6):398-402. PubMed ID: 2851416 [No Abstract] [Full Text] [Related]
51. Antigens on human plasma cells identified by monoclonal antibodies. Anderson KC; Park EK; Bates MP; Leonard RC; Hardy R; Schlossman SF; Nadler LM J Immunol; 1983 Mar; 130(3):1132-8. PubMed ID: 6401780 [TBL] [Abstract][Full Text] [Related]
52. Production of hybrids of mouse myeloma cells and protozoa which express parasite antigens. Rodriguez-Lopez MH; Crocker PR; Harrison TJ; Targett GA; Bradley DJ Immunology; 1984 Aug; 52(4):727-32. PubMed ID: 6378772 [TBL] [Abstract][Full Text] [Related]
53. Monoclonal antibodies. Clinical relevance to pediatrics. Insel RA; Gigliotti F Am J Dis Child; 1983 Jan; 137(1):69-76. PubMed ID: 6336635 [TBL] [Abstract][Full Text] [Related]
54. The multicellular (as opposed to the monoclonal) origin of the murine myeloma cell. Warner TF; Krueger RG J Theor Biol; 1975 Oct; 54(2):175-9. PubMed ID: 173929 [No Abstract] [Full Text] [Related]